1. Home >
  2. Companies >
  3. Public >
  4. Healthcare Services >
  5. United States >
  6. Amneal Pharmaceuticals >
  7. M&A

Amneal Pharmaceuticals Mergers & Acquisitions

Amneal Pharmaceuticals M&A Summary

Amneal Pharmaceuticals has acquired 6 companies, including 2 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.

Amneal Pharmaceuticals’ largest acquisition to date was in 2019, when it acquired AvKARE for $340M. Amneal Pharmaceuticals has acquired in 5 different US states. The Company’s most targeted sectors include life science (84%) and medical products (17%).

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity6
    • M&A Sell Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 4

Amneal Pharmaceuticals

Amneal Pharmaceuticals, Inc.

400 Crossing Boulevard, 3rd Floor,
Bridgewater, New Jersey 08807
United States,
(908) 947-3120
www.amneal.com

All (8) Buy (6) Sell (2)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2022-01-05 Saol Therapeutics - Baclofen Franchise · Life Science
Roswell, Georgia

Saol Therapeutics' Baclofen Franchise is a pipeline product under development. Lioresal® is an intrathecal baclofen product delivered through an implantable intrathecal pump for use in the management of severe spasticity of cerebral or spinal origin for the institutional market. LYVISPAHTM is a baclofen oral granules (5, 10, and 20 mg) specialty product recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of spasticity.

- Divestiture

Amneal Pharmaceuticals

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal